BIOG — Biotech Growth Trust Balance Sheet
0.000.00%
Last trade - 00:00FinancialsBalancedSmall Cap
- £241.31m
- £232.85m
- -£77.53m
Annual balance sheet for Biotech Growth Trust, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.5 | 0 | 2.77 | 2.13 | 8.45 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6.26 | 0.049 | 3.28 | 16.7 | 8.47 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 650 | 427 | 361 | 411 | 227 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 48.1 | 33.2 | 30.2 | 50.1 | 5.42 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 48.1 | 33.2 | 30.2 | 50.1 | 5.42 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 601 | 394 | 330 | 361 | 221 |
| Total Liabilities & Shareholders' Equity | 650 | 427 | 361 | 411 | 227 |
| Total Common Shares Outstanding |